Proshares Ultra Nasdaq Biotechnology ETF Forecast

Buy or Hold candidate since Jun 11, 2026 Gain 18.97%

The ProShares Ultra Nasdaq Biotechnology ETF price fell by -1.16% on the last day (Friday, 24th Jul 2026) from $99.04 to $97.88. During the last trading day the ETF fluctuated 1.79% from a day low at $97.68 to a day high of $99.43. The price has fallen in 6 of the last 10 days and is down by -4.9% for this period. Volume has increased on the last day by 1 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 3 thousand shares were bought and sold for approximately $339.55 thousand.

The ETF lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the ETF is expected to rise 28.84% during the next 3 months and, with a 90% probability hold a price between $116.95 and $148.61 at the end of this 3-month period.

BIB Signals & Forecast

A sell signal was issued from a pivot top point on Tuesday, July 07, 2026, and so far it has fallen -10.89%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). ProShares Ultra Nasdaq Biotechnology gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". Some positive signals were issued as well, and these may have some influence on the near short-term development. The ProShares Ultra Nasdaq Biotechnology ETF holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the ETF giving a positive forecast for the ETF. On further gains, the ETF will meet resistance from the short-term Moving Average at approximately $98.63. On a fall, the ETF will find some support from the long-term average at approximately $94.25. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal.

Support, Risk & Stop-loss for ProShares Ultra Nasdaq Biotechnology ETF

On the downside, the ETF finds support just below today's level from accumulated volume at $92.31 and $89.74. There is a natural risk involved when a ETF is testing a support level, since if this is broken, the ETF then may fall to the next support level. In this case, ProShares Ultra Nasdaq Biotechnology finds support just below today's level at $92.31. If this is broken, then the next support from accumulated volume will be at $89.74 and $82.90.

This ETF has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the ETF moved $1.75 between high and low, or 1.79%. For the last week, the ETF has had daily average volatility of 2.64%.

Our recommended stop-loss: $93.18 (-4.80%) (This ETF has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 13 days ago.)

Trading Expectations (BIB) For The Upcoming Trading Day Of Monday 27th

For the upcoming trading day on Monday, 27th we expect ProShares Ultra Nasdaq Biotechnology to open at $98.33, and during the day (based on 14 day Average True Range), to move between $96.23 and $99.54, which gives a possible trading interval of +/-$3.31 (+/-3.44%) up or down from last closing price. If ProShares Ultra Nasdaq Biotechnology takes out the full calculated possible swing range there will be an estimated 3.44% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $98.28 (0.41%) than the support at $92.31 (5.69%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is ProShares Ultra Nasdaq Biotechnology ETF A Buy?

Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.

Current score: 2.368 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 27, 2026 - $98.33 ( 0.458%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk